3,687
Views
53
CrossRef citations to date
0
Altmetric
Research Article

Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and neurotoxicity in Wistar rats

, &
Pages 146-155 | Received 17 Sep 2015, Accepted 30 Aug 2016, Published online: 27 Sep 2016

References

  • Abahji TN, Nill L, Ide N, Keller C, Hoffmann U, Weiss N. 2007. Acute hyperhomocysteinemia induces microvascular and macrovascular endothelial dysfunction. Arch Med Res. 38:411–416.
  • Atkinson J. 2001. Cerebrovascular structure and dementia: new drug targets. Trends Pharmacol Sci. 22:630–635.
  • Balakrishnan A, Menon VP. 2007. Protective effect of hesperidin on nicotine induced toxicity in rats. Indian J Exp Biol. 45:194–202.
  • Baydas G, Ozer M, Yasar A, Tuzcu M, Koz ST. 2005. Melatonin improves learning and memory performances impaired by hyperhomocysteinemia in rats. Brain Res. 1046:187–194.
  • Chance B, Maehly AC. 1955. Assay of catalase and peroxidases. Methods Enzymol. 11:764–775.
  • Chanet A, Milenkovic D, Manach C, Mazur A, Morand C. 2012. Citrus flavanones: what is their role in cardiovascular protection? J Agric Food Chem. 60:8809–8822.
  • Cho J. 2006. Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin. Arch Pharm Res. 29:699–706.
  • Coyle JT, Puttfarcken P. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:689–695.
  • Dayal S, Devlin AM, McCaw RB, Liu ML, Arning E, Bottiglieri T, Shane B, Faraci FM, Lentz SR. 2005 . Cerebral vascular dysfunction in methionine synthase-deficient mice. Circulation. 112:737–744.
  • Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys. 82:70–77.
  • Ellman GL, Courtney KD, Andres V, Jr., Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
  • Emim JA, Oliveira AB, Lapa AJ. 1994. Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid, hesperidin, and the isoflavonoids, duartin and claussequinone, in rats and mice. J Pharm Pharmacol. 46:118–122.
  • Hankey GJ, Eikelboom JW. 1999. Homocysteine and vascular disease. Lancet. 354:407–413.
  • Heinecke JW. 1988. Superoxide mediated oxidation of low density lipoprotein by thiols. In: Cerutti PA, Fridovich I, Mc Cord JM, editors. Oxy-radicals in molecular biology and pathology. New York (NY): Alan R Liss; pp. 443–457.
  • Herrmann W, Obeid R. 2011 . Homocysteine: a biomarker in neurodegenerative diseases. Clin Chem Lab Med. 49:435–441.
  • Hirata A, Murakami Y, Shoji M, Kadoma Y, Fujisawa S. 2005. Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression. Anticancer Res. 25:3367–3374.
  • Hughes RN. 2004. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev. 28:497–505.
  • Jiang X, Yang F, Tan H, Liao D, Bryan RM, Jr., Randhawa JK, Rumbaut RE, Durante W, Schafer AI, Yang X, et al. 2005. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol. 25:2515–2521.
  • Kawaguchi K, Mizuno T, Aida K, Uchino K. 1997. Hesperidin as an inhibitor of lipases from porcine pancreas and Pseudomonas. Biosci Biotechnol Biochem. 61:102–104.
  • Kemse NG, Kale AA, Joshi SR. 2014. A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension. PLoS One. 9:e111902.
  • Kim JY, Jung KJ, Choi JS, Chung HY. 2004. Hesperetin: a potent antioxidant against peroxynitrite. Free Radic Res. 38:761–769.
  • Koladiya RU, Jaggi AS, Singh N, Sharma BK. 2008. Ameliorative role of atorvastatin and pitavastatin in l-methionine induced vascular dementia in rats. BMC Pharmacol. 8:14.
  • Koladiya RU, Jaggi AS, Singh N, Sharma BK. 2009. Beneficial effects of donepezil on vascular endothelial dysfunction-associated dementia induced by l-methionine in rats. J Health Sci. 55:215–225.
  • Kumar P, Kumar A. 2010. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res. 206:38–46.
  • Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. 2003. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 111:1201–1209.
  • Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, Faraci FM. 2000. Folate dependence of hyperhomocysteinemia and endothelial dysfunction in cystathionine-synthase-deficient mice. Am J Physiol Heart Circ Physiol. 279:H970–H975.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
  • Maher P. 2008. The flavonoid fisetin promotes nerve cell survival from trophic factor withdrawal by enhancement of proteasome activity. Arch Biochem Biophys. 476:139–144.
  • Maher P, Akaishi T, Abe K. 2006. Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci USA. 103:16568–16573.
  • Mans A, Chowdhury N, Cao D, McMahon LL, Li L. 2010. Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice. Neuroscience. 166:435–444.
  • Marklund S, Marklund G. 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 47:469–474.
  • Morris RGM. 1984. Developments of a water maze producer for studying spatial learning in the rats. J Neurosci Methods. 11:47–60.
  • Obeid R, Herrmann W. 2006. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580:2994–3005.
  • Olanow CW. 1993. A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease. Mov Disord. 8:S1–S7.
  • Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M. 2015. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res. 29:323–331.
  • Pieper GM. 1997 . Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res. 34:145–156.
  • Reddy DS. 1997. Assessment of nootropic and amnesic activity of centrally acting agents. Indian J Pharmacol. 29:208–221.
  • Rice-Evans CA, Miller NJ, Paganga G. 1996. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med. 20:933–956.
  • Sain H, Sharma B, Jaggi AS, Singh N. 2011. Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia induced vascular dementia in rats. Neuroscience. 192:322–333.
  • Sastry KVH, Moudgal RP, Mohan J, Tyagi JS, Rao GS. 2002. Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem. 306:79–82.
  • Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. 2002. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 346:476–483.
  • Shah DI, Singh M. 2006 . Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction. Vascul Pharmacol. 44:177–182.
  • Shah DI, Singh M. 2007. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats. Mol Cell Biochem. 295:65–74.
  • Sharma B, Singh N. 2011. Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats. Pharmacol Biochem Behav. 100:320–329.
  • Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. 1993. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 91:308–318.
  • Stefanello FM, Monteiro SC, Matté C, Scherer EB, Netto CA, Wyse AT. 2007. Hypermethioninemia increases cerebral acetylcholinesterase activity and impairs memory in rats. Neurochem Res. 32:1868–1874.
  • Streck EL, Bavaresco CS, Netto CA, Wyse AT. 2004. Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task. Behav Brain Res. 153:377–381.
  • Suarez J, Herrera MD, Marhuenda E. 1998 . In vitro scavenger and antioxidant properties of hesperidin and neohesperidin dihydrochalcone. Phytomedicine. 5:469–473.
  • Unger BS, Patil BM. 2009. Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat. Indian J Pharmacol. 41:208–212.
  • Vorhees CV, Williams MT. 2006. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 1:848–858.
  • Wills ED. 1969 . Lipid peroxide formation in microsomes. Relationship of hydroxylation to lipid peroxide formation. Biochem. J. 113:333–341.
  • Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A, Casadesus G, Harris PL, Siedlak SL, Perry G. 2007. Vascular oxidative stress in Alzheimer disease. J Neurol Sci. 257:240–246.